FDA Extends Comment Period on Sesame Labeling
In November 2020 the U.S. Food and Drug Administration (FDA) issued its draft guidance regarding the voluntary disclosure of sesame as an allergen. The deadline for comments has now been extended to February 25, 2021. This 45 day extension gives the allergy advocacy community another opportunity to provide critical input on this important issue. Comments need to be sent prior to the deadline to ensure that the FDA can evaluate them prior to their starting work on the final guidance.
By Staff of www.foodsafetymagazine.com
January 4th, 2021
The U.S. Food and Drug Administration (FDA) has announced that it is extending the comment period on its draft guidance regarding voluntary disclosure of sesame as an allergen to February 25, 2021, an extension of 45 days. Comments should be submitted before February 25, 2021 to ensure that FDA considers them before beginning work on the final guidance.
Comments on the draft voluntary sesame labeling guidance should be submitted to http://www.regulations.gov.
Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville MD 20852. All written comments should be identified with this document's docket number: FDA-2020-D-0530.
Lisa Gable, CEO of Food Allergy Research & Education, stated that her organization is “grateful for the extension as it affords an opportunity for the 1.5 million who are allergic to sesame and the more than 32 million Americans suffering from potentially life-threatening food allergies to share their thoughts and feelings on this incredibly important issue.”
Read the original announcement here.